Study Stopped
PI departure from institution
Optimizing Treatment Effects on OSA-related Clinical and Patient-centered Outcomes Among Blacks
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The study is to maximize efficacy of message delivery to achieve desired Obstructive sleep apnea (OSA) adherence goal. Newly diagnosed black patients (n=390, all genders) from participating sleep clinics will be randomly exposed to either the individually tailored or standard OSA messages. Investigators will look at an effective and scalable intervention to improve OSA-related outcomes: a) clinical CVD and brain health measures and b) patient-centered outcomes. Patient-centered and adherence data will be captured via REDCap, enabling real-time application of data-driven decision rules while implementing the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2017
CompletedFirst Posted
Study publicly available on registry
November 28, 2017
CompletedStudy Start
First participant enrolled
June 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 18, 2021
CompletedFebruary 9, 2022
February 1, 2022
Same day
November 21, 2017
February 7, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change from Baseline OSA Self-Efficacy Scale Score to 6 Months Score
The mean of the nonmissing item responses was calculated for each of the 3 subscales: Perceived Risk, Outcome Expectancies, and Treatment Self-Efficacy. Using this mean-weighted score prevents the distortion of the score from missing responses. Factor 1 (Risk Perception consisting of 8 questions); Factor 2 (Outcome Expectancy consisting of 9 items) and Factor 3 (Treatment Self Efficacy consisting of 9 items) are given a potential score of 1-4.
2 Months and 6 Months
Study Arms (3)
Tailored Videos
ACTIVE COMPARATORStandard Videos
ACTIVE COMPARATOROSA Treatment
ACTIVE COMPARATORInterventions
web-based OSA messages (videos featuring role models and coaching advice using motivational enhancement) addressing OSA barriers within a health literacy framework--to decrease cognitive load and render messages understandable and actionable. OSA messages were tailored based on focus group data in the previous study (group tailoring).
Web-based platform delivering messages promoting OSA self-efficacy. . All patients will view the introductory video, followed by the video cluster: Sleep, Health, and Well-Being; Sleep-Heart Health; Lifestyle Changes; and Sleep Hygiene.
Patients in the control arm will also receive an iPad, providing access to standard online OSA health information (e.g., National Sleep Foundation) in an equivalent dose as in the intervention arm using pre-selected automatic alerts to access the website
Eligibility Criteria
You may qualify if:
- Self-reported race/ethnicity as African American, African, Caribbean or black
- Accessible by phone
- No plans to move away within the year
- OSA diagnosis, consent, including permission to release medical data
- Physician-diagnosed medical conditions.
You may not qualify if:
- Progressive illnesses in which disability or death is expected within 1 year
- Impaired cognitive/ functional ability precluding participation
- Intention to move within the same year of enrollment
- Family member currently enrolled
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Girardin Jean-Louis, PhD
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2017
First Posted
November 28, 2017
Study Start
June 18, 2021
Primary Completion
June 18, 2021
Study Completion
June 18, 2021
Last Updated
February 9, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 3 months and ending 5 years following article publication.
- Access Criteria
- Requests should be directed to Ferdinand.Zizi@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
All of the individual participant data collected during the trial, after deidentification.